Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals

Clin Pharmacokinet. 2006;45(2):213-4; author reply 214-5. doi: 10.2165/00003088-200645020-00006.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Alkynes
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacokinetics*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Benzoxazines
  • Cyclopropanes
  • Cytochrome P-450 CYP2B6
  • HIV Infections / metabolism*
  • HIV-1*
  • Humans
  • Oxazines / metabolism
  • Oxazines / pharmacokinetics*
  • Oxidoreductases, N-Demethylating / genetics*
  • Polymorphism, Genetic

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Aryl Hydrocarbon Hydroxylases
  • CYP2B6 protein, human
  • Cytochrome P-450 CYP2B6
  • Oxidoreductases, N-Demethylating
  • efavirenz